| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/18/2001 | CN1064541C Medicine for treating gynecological chronic inflammation |
| 04/18/2001 | CN1064532C Pill for pelvic inflammation and cervical erosion |
| 04/17/2001 | US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated |
| 04/17/2001 | US6218425 Useful in the treatment of estrogen-related disorders such as osteoporosis, hyperlipidemia, estrogen-related breast cancer, uterine fibrosis, endometriosis, and restenosis |
| 04/17/2001 | US6218415 Therapy of bone reabsorption by osteoclasts, tumor growth and tumor metastasis, inflammation, cardiovascular disease, nephropathies and retinopathies |
| 04/17/2001 | US6218400 Treating angina, hypertension, pulmonary disease, vascular disorders, stroke, bronchitis, asthma, rhinitis, glaucoma, sexual disorders, and disorders of gut motility |
| 04/17/2001 | US6218390 Morpholinone and morpholine derivatives and uses thereof |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218371 Administering immunopotentiating cytokine selected from group consisting of gm-csf, il-2, il-4 and ifn-.gamma., and immunostimulatory cpg oligonucleotide for inducing synergistic antigen specific immune response |
| 04/17/2001 | US6218369 Administering flavanolignane selected from silymarin, silybin, silidianin, silicristin, dehydrosilybin, phospholipid complex of one of these flavanolignanes, and mixtures, in combination with antitumor agent |
| 04/17/2001 | CA2157003C Hormone replacement therapy |
| 04/17/2001 | CA2156742C Phosphonomethyldipeptides |
| 04/14/2001 | CA2286451A1 Hormone-sensitive lipase mediated male infertility |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 04/12/2001 | WO2001024800A1 Erection insufficiency remedies |
| 04/12/2001 | WO2001024788A2 Treating endometriosis or infertility, or improving fertility |
| 04/12/2001 | WO2001024772A1 Formulation for menopausal women |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090915A1 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[-4-(methylsulfonyl)phenyl]- 5,5-dimethyl-5H-furan-2-one |
| 04/11/2001 | EP1090641A2 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090029A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds |
| 04/11/2001 | EP1090028A1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 04/11/2001 | EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/11/2001 | EP1090010A1 Thienopyridine compounds, their production and use |
| 04/11/2001 | EP1090003A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 04/11/2001 | EP1089742A2 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein |
| 04/11/2001 | EP1089736A2 Method and compositions for the treatment or amelioration of female sexual dysfunction |
| 04/11/2001 | EP1089722A1 Matrix-type transdermal patch for steroid hormones |
| 04/11/2001 | EP1089719A2 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/11/2001 | EP1089679A1 A device and method for the treatment of erectile dysfunction |
| 04/11/2001 | CN1291192A 5,6,7-trino-4,8-inter-m-phenylene PGI2 derivative and drugs containing the same |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1291101A Regulation of estrus and ovulation in gilts |
| 04/11/2001 | CN1290553A Capsule for tonifying kidney |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/11/2001 | CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists |
| 04/11/2001 | CN1064238C Injection for castracting animals |
| 04/10/2001 | US6214849 Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function in mammals including humans |
| 04/10/2001 | US6214815 Triphasic oral contraceptive |
| 04/10/2001 | US6214798 Polypeptides |
| 04/10/2001 | US6214795 Polypetides with amino acid sequences |
| 04/10/2001 | US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214342 Method for increasing mean survival times of transplants with LFA-1-specific antibodies |
| 04/05/2001 | WO2001023588A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023424A1 A phosphatidylethanolamine binding protein (pebp-2) and uses thereof |
| 04/05/2001 | WO2001023422A1 Vaccine |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023389A2 Certain alkylene diamine-substituted heterocycles |
| 04/05/2001 | WO2001023388A2 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023387A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023381A1 Piperidine derivatives as reuptake inhibitors |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022961A1 New use of modafinil and the d/l enantiomer |
| 04/05/2001 | WO2001022907A1 Drug delivery of phase changing formulation |
| 04/05/2001 | WO2000073334A3 Human sorting nexins |
| 04/05/2001 | WO2000067788A3 Use of soluble costimulatory molecules to enhance immune responses |
| 04/05/2001 | WO2000066103A3 Contraceptive compositions containing cyclic urea and amide derivatives |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000040228A3 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
| 04/05/2001 | CA2386092A1 Piperidine derivatives |
| 04/05/2001 | CA2385883A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384723A1 Vaccine |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/04/2001 | EP1088067A1 Methods and compositions for modulating spermatogenesis |
| 04/04/2001 | EP1087988A1 Meiosis regulating compounds |
| 04/04/2001 | EP1087986A1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity |
| 04/04/2001 | EP1087978A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 04/04/2001 | EP1087964A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
| 04/04/2001 | EP1087963A1 Inhibitors of glycogen synthase kinase 3 |
| 04/04/2001 | EP1087961A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 04/04/2001 | EP1087959A1 Novel benzopyran or thiobenzopyran derivatives |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | EP1087787A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 04/04/2001 | EP1087786A1 Methods and materials for the treatment of prostatic carcinoma |
| 04/04/2001 | EP1087773A1 Vaginal active agent delivery procedures and formulations thereof |
| 04/04/2001 | EP0636127B1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 04/04/2001 | CN1290260A Hydroxamic and carboxylic acid derivatives |
| 04/04/2001 | CN1290258A Arylpiperazines having activity at the serotnin 1A receptor |
| 04/04/2001 | CN1289608A Chinese medicine 'Sanrupi' for treating mastoplasia |
| 04/04/2001 | CN1289604A Medicine for increasing spermic and helping conception |
| 04/04/2001 | CN1289603A Medicine for nourishing kidney, circulating blood, helping conception and removing spots |
| 04/03/2001 | US6211242 Benzamide derivatives as vasopressin antagonists |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 04/03/2001 | US6211233 Prostaglandin pharmaceutical compositions |
| 04/03/2001 | US6211222 Substituted indazole derivatives and related compounds |
| 04/03/2001 | US6211210 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |